By Inga Orozco and Kristin Orrell Life sciences companies operate at the leading edge of innovation, structuring high-value licensing, development, and outsourcing arrangements in a highly regulated environment. A persistent and often underappreciated financial reporting risk arises not in the laboratory but at the intersection of contract drafting and accounting interpretation.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile